Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen Cancer Drugs Slow March of Deadly Tumors, Studies Suggest
Amgen Cancer Drugs Slow March of Deadly Tumors, Studies Suggest
Amgen Cancer Drugs Slow March of Deadly Tumors, Studies Suggest
Submitted by
admin
on May 20, 2010 - 6:29pm
Source:
Bloomberg
News Tags:
Amgen
cancer
pancreatic cancer
ovarian cancer
conatumumab
Headline:
Amgen Cancer Drugs Slow March of Deadly Tumors, Studies Suggest
Do Not Allow Advertisers to Use My Personal information
